Home-based pulmonary rehabilitation and health coaching for lung fibrosis patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effects of a home-based pulmonary rehabilitation program combined with health coaching on the quality of life and physical activity of patients suffering from fibrotic interstitial lung disease (f-ILD). The study compares this intervention to usual care, focusing on improving access to rehabilitation for patients who may not be able to participate in traditional center-based programs. The primary hypothesis is that this modified approach will lead to significant improvements in patient-reported outcomes related to respiratory health and overall well-being.

Why it matters

Who can join: the full rules

IInclusion Criteria:

* F-ILD diagnosis, any disease subtype, active or prior medical treatment
* \>10% fibrosis on CT imaging
* mMRC dyspnea score \>1
* All racial or ethnic categories, including non-English speakers (professional translators will be engaged to support screening, enrollment, and study participation)

Exclusion Criteria:

* Inability to walk (orthopedic/neurologic/cardiac limitation causing immobility)
* Cognitive impairment or inability to understand and follow instructions
* Traditional center-based PR completed within 3 months of initial study recruitment
* Transition to hospice or end-of-life care at the time of screening
* Acute exacerbation at the time of screening

Where it's running

• Mayo Clinic in Arizona
  Scottsdale, Arizona, United States Recruiting
• Mayo Clinic in Florida
  Jacksonville, Florida, United States Recruiting
• University of Minnesota
  Minneapolis, Minnesota, United States Recruiting
• Mayo Clinic in Rochester
  Rochester, Minnesota, United States Recruiting

Study contacts

• Principal investigator: Teng Moua — Mayo Clinic
• Study coordinator: Johanna Hoult, MS
• Email: hoult.johanna@mayo.edu
• Phone: 507-293-1989

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Do airway mucus plugs cause lung scarring in people with COPD undergoing lung cancer surgery

  This study will see if airway mucus plugs in people with COPD are linked to lung scarring by analyzing lung tissue and mucus collected during lung cancer operations.

  Recruiting Shanghai Zhongshan Hospital · Shanghai · NCT07236541

• Evaluating FAP as a biomarker for fibrotic lung diseases

  This study is testing if a protein called FAP can help doctors understand and track fibrotic lung diseases like idiopathic pulmonary fibrosis by looking at its levels in different samples and using special scans before and after treatments.

  Recruiting Phase 2 Erasme University Hospital · Brussels · NCT06189820

• Registry for individuals affected by pulmonary fibrosis

  This study invites people with pulmonary fibrosis, along with their caregivers and family members, to share their experiences through online surveys to help researchers understand the condition better and possibly reach out for future studies.

  Recruiting Pulmonary Fibrosis Foundation · Chicago, Illinois · NCT05382572

• Using exosomes to modulate the immune response in critically ill COVID-19 patients

  This study is testing whether exosomes from stem cells can help improve the immune response and reduce inflammation in critically ill COVID-19 patients.

  Recruiting University of Ulm · Ulm · NCT05191381

• Telitacicept for primary Sjögren’s with interstitial lung disease

  This study tests whether Telitacicept helps people with primary Sjögren’s syndrome and interstitial lung disease compared with standard immunosuppressants.

  Recruiting Peking University People's Hospital · Beijing · NCT07843381

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.